Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Lillian Brady receives McKnight Scholar Award
9+ hour, 56+ min ago (287+ words) Lillian Brady was selected to receive a 2026 McKnight Scholar Award from The McKnight Endowment Fund for Neuroscience. The award recognizes early-career scientists who are establishing independent research programs and advancing neuroscience. The McKnight Scholar Awards have supported innovative neuroscience investigators…...
AI Agents Could Cure Cancer by Dec 2030 via Nerve Targeting
13+ hour, 12+ min ago (1475+ words) By David Stephen “neurons and nerves — via a variety of mechanisms that researchers are still teasing apart — seem to regulate almost everything about cancer, from tumor initiation in many cases to tumor growth, tumor invasion and metastasis, probably resistance to…...
PIMS 2017-2026: progress, lessons and the evidence gap
12+ hour, 20+ min ago (349+ words) This is the second in a three-part editorial series on the Pacific Meteorological Council (PMC), the Pacific Islands Meteorological Strategy (PIMS) and Weather Ready Pacific (WRP). All information used is sourced from the PCM-8 Agenda. Dedicated meteorological legislation rose from…...
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene Therapy
10+ hour, 46+ min ago (739+ words) PR Newswire SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies…...
AstraZeneca's Phase 3 Trial of Combination Treatment for Breast Cancer Fails to Meet Primary Endpoint
11+ hour, 47+ min ago (48+ words) Published on 09/13/2026 at 11:24 pm EDT AstraZeneca: Share price weakness of late, should be capitalised on September 04, 2026 at 08:13 am EDT AstraZeneca Is Said to Have Explored Bristol Myers Merger Heading for a major healthcare merger between AstraZeneca and Bristol-Myers Squibb?...
Marcela Carena to headline 2026 Ewan Memorial Lecture in Kingston – Kingston News
12+ hour, 26+ min ago (227+ words) One of the world’s leading theoretical physicists is coming to Kingston this week to explore some of the biggest mysteries of the universe. Professor Marcela Carena of the Perimeter Institute for Theoretical Physics will deliver the 2026 Ewan Memorial Lecture on…...
Beyond Detection: Coreline Soft Sees Lung Cancer Screening AI Evolving into a Digital Pathway
12+ hour, 11+ min ago (861+ words) The global race in artificial intelligence for lung cancer screening is beginning to move beyond a familiar question: how accurately can an algorithm detect a pulmonary nodule? As screening programs expand, a broader challenge is emerging. AI must work not…...
Hengrui Pharmaceuticals' Lung Cancer Drug Included in China's Breakthrough Therapy Designation List
12+ hour, 25+ min ago (69+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Jiangsu Hengrui Pharmaceuticals Co.,Ltd Hengrui Pharmaceuticals' Lung Cancer…...
Justin Gooding’s journey from discovery to impact
15+ hour, 51+ min ago (1530+ words) Scientia Professor Justin Gooding speaking at the celebratory event held in his honour. Colleagues, collaborators and former students gathered at UNSW to celebrate Scientia Professor Justin Gooding’s 60th birthday and his career translating research into real-world technologies. UNSW Scientia Professor Justin…...